Related Experiment Video
Updated: Mar 25, 2026
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
31.0K
Antiviral therapy: a perspective
1Clinician Scientist, Institute of Applied Research in Dentistry, Kerman University of Medical Sciences, Kerman, Iran.
Drug Design, Development and Therapy
|February 20, 2016
Summary
This study proposes a novel extracorporeal viral antibody column (EVAC) to remove viral particles and toxins from blood, potentially improving outcomes for chronic blood-borne viral infections, especially in the elderly.
Area of Science:
- Virology
- Immunology
- Medical Technology
Background:
- Chronic blood-borne viral infections persist, weakening the immune system and increasing disease severity.
- Viral load correlates with disease severity; reduction can alleviate symptoms and improve health.
- Elderly individuals are particularly vulnerable to viral infections, with some infections being life-threatening.
Purpose of the Study:
- To propose a novel therapeutic approach for reducing viral load in blood-borne infections.
- To introduce the concept of an extracorporeal viral antibody column (EVAC) for auxiliary therapy.
- To hypothesize the potential benefits of EVAC in managing viral infections, particularly in vulnerable populations.
Main Methods:
- The proposed method involves an extracorporeal circuit using a viral antibody column (EVAC).
- EVAC is designed to selectively trap viral antigens and toxins from the blood.
- Detoxified blood is returned to the patient's body.
Main Results:
- The hypothesis suggests EVAC can reduce blood viral titers and associated toxins.
- This reduction is anticipated to improve patient health and overall performance.
- EVAC could enhance the efficacy of conventional antiviral therapies.
Conclusions:
- EVAC presents a novel auxiliary therapy for blood-borne viral infections.
- The approach may significantly reduce mortality in the elderly and improve outcomes for lethal viral infections like Ebola.
- Further research and animal model validation are necessary before human application as a supportive treatment.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
50.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K
01:30Inhibitors of Viral Protein Synthesis
16
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
16
02:33Retroviruses
15.7K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.7K
01:29Subviral Agents
737
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
737
01:26Human Virome
32
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
32
01:29Immune Response Against Viral Pathogens
2.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K